SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 258 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $48,000 | +152.6% | 300 | -14.3% | 0.01% | +120.0% |
| Q4 2017 | $19,000 | -24.0% | 350 | -36.4% | 0.01% | -16.7% |
| Q3 2017 | $25,000 | +13.6% | 550 | -15.4% | 0.01% | 0.0% |
| Q2 2017 | $22,000 | +22.2% | 650 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $18,000 | 0.0% | 650 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $18,000 | -51.4% | 650 | +8.3% | 0.01% | -50.0% |
| Q3 2016 | $37,000 | +236.4% | 600 | 0.0% | 0.01% | +200.0% |
| Q2 2016 | $11,000 | -8.3% | 600 | 0.0% | 0.00% | -20.0% |
| Q1 2016 | $12,000 | -53.8% | 600 | -25.0% | 0.01% | -58.3% |
| Q3 2015 | $26,000 | – | 800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |